

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding and management... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-68/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-68" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding and management of acquired thrombocytopenia" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding and management of acquired thrombocytopenia.">
            <meta name="og:description" content="Read the latest article version by Srikanth Nagalla, Ravindra Sarode, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13324">
            <meta name="article-id" content="12309">
            <meta name="dc.title" content="Recent advances in understanding and management of acquired thrombocytopenia">
            <meta name="dc.description" content="There are numerous congenital and acquired causes of thrombocytopenia. Thrombocytopenia could be a result of decreased bone marrow production, increased consumption, increased destruction, splenic sequestration or a combination of these causes. In this review, we have focused on some of the serious acquired causes of thrombocytopenia. There have been some significant advances in our understanding of the pathophysiology, diagnostic testing, and treatment of immune thrombocytopenia, heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome over the past five years. These advances have resulted in a significant decrease in mortality and morbidity of patients with these disorders. Despite these advances, we are still faced with numerous unanswered questions in the pathophysiology and management of these complex thrombocytopenic disorders.">
            <meta name="dc.subject" content="Thrombocytopenia, immune, heparin, thrombotic thrombocytopenic purpura, atypical hemolytic uremic">
            <meta name="dc.creator" content="Nagalla, Srikanth">
            <meta name="dc.creator" content="Sarode, Ravindra">
            <meta name="dc.date" content="2018/01/17">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12309.1">
            <meta name="dc.source" content="F1000Research 2018 7:68">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Thrombocytopenia">
            <meta name="prism.keyword" content="immune">
            <meta name="prism.keyword" content="heparin">
            <meta name="prism.keyword" content="thrombotic thrombocytopenic purpura">
            <meta name="prism.keyword" content="atypical hemolytic uremic">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/01/17">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="68">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12309.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-68">
            <meta name="citation_title" content="Recent advances in understanding and management of acquired thrombocytopenia">
            <meta name="citation_abstract" content="There are numerous congenital and acquired causes of thrombocytopenia. Thrombocytopenia could be a result of decreased bone marrow production, increased consumption, increased destruction, splenic sequestration or a combination of these causes. In this review, we have focused on some of the serious acquired causes of thrombocytopenia. There have been some significant advances in our understanding of the pathophysiology, diagnostic testing, and treatment of immune thrombocytopenia, heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome over the past five years. These advances have resulted in a significant decrease in mortality and morbidity of patients with these disorders. Despite these advances, we are still faced with numerous unanswered questions in the pathophysiology and management of these complex thrombocytopenic disorders.">
            <meta name="citation_description" content="There are numerous congenital and acquired causes of thrombocytopenia. Thrombocytopenia could be a result of decreased bone marrow production, increased consumption, increased destruction, splenic sequestration or a combination of these causes. In this review, we have focused on some of the serious acquired causes of thrombocytopenia. There have been some significant advances in our understanding of the pathophysiology, diagnostic testing, and treatment of immune thrombocytopenia, heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome over the past five years. These advances have resulted in a significant decrease in mortality and morbidity of patients with these disorders. Despite these advances, we are still faced with numerous unanswered questions in the pathophysiology and management of these complex thrombocytopenic disorders.">
            <meta name="citation_keywords" content="Thrombocytopenia, immune, heparin, thrombotic thrombocytopenic purpura, atypical hemolytic uremic">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Srikanth Nagalla">
            <meta name="citation_author_institution" content="Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA">
            <meta name="citation_author" content="Ravindra Sarode">
            <meta name="citation_author_institution" content="Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA">
            <meta name="citation_publication_date" content="2018/01/17">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="68">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12309.1">
            <meta name="citation_firstpage" content="68">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-68/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-68.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13324 /> <input type=hidden id=articleId name=articleId value=12309 /> <input type=hidden id=xmlUrl value="/articles/7-68/v1/xml"/> <input type=hidden id=xmlFileName value="-7-68-v1.xml"> <input type=hidden id=article_uuid value=90dc86e1-fbac-47ca-802b-b29c0f9c828d /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding and management of acquired thrombocytopenia"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12309.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12309.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-68"
  },
  "headline": "Recent advances in understanding and management of acquired thrombocytopenia",
  "datePublished": "2018-01-17T10:06:02",
  "dateModified": "2018-01-17T10:06:02",
  "author": [
    {
      "@type": "Person",
      "name": "Srikanth Nagalla"
    },    {
      "@type": "Person",
      "name": "Ravindra Sarode"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "There are numerous congenital and acquired causes of thrombocytopenia. Thrombocytopenia could be a result of decreased bone marrow production, increased consumption, increased destruction, splenic sequestration or a combination of these causes. In this review, we have focused on some of the serious acquired causes of thrombocytopenia. There have been some significant advances in our understanding of the pathophysiology, diagnostic testing, and treatment of immune thrombocytopenia, heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome over the past five years. These advances have resulted in a significant decrease in mortality and morbidity of patients with these disorders. Despite these advances, we are still faced with numerous unanswered questions in the pathophysiology and management of these complex thrombocytopenic disorders."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-68.html",
            "name": "Recent advances in understanding and management of acquired thrombocytopenia"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding and management of acquired thrombocytopenia </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13324 data-id=12309 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12309.1" data-recommended="" data-doi="10.12688/f1000research.12309.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-68/v1/pdf?article_uuid=90dc86e1-fbac-47ca-802b-b29c0f9c828d" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12309-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12309-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12309-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Nagalla S and Sarode R. Recent advances in understanding and management of acquired thrombocytopenia [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):68 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12309.1" target=_blank>https://doi.org/10.12688/f1000research.12309.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12309-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12309 id=track-article-signin-12309 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12309?target=/articles/7-68.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13324 /> <input name=articleId type=hidden value=12309 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding and management of acquired thrombocytopenia</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Srikanth Nagalla<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:ravi.sarode@utsouthwestern.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ravindra Sarode</span></a><a href="https://orcid.org/0000-0003-4199-5158" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4199-5158</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Srikanth Nagalla<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:ravi.sarode@utsouthwestern.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Ravindra Sarode</span></a><a href="http://orcid.org/0000-0003-4199-5158" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4199-5158</div><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 17 Jan 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12309.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA<br/> <sup>2</sup> Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA<br/> <p> <div class=margin-bottom> Srikanth Nagalla <br/> <span>Roles: </span> Conceptualization, Resources, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ravindra Sarode <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=29586-29606></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=29585-29607></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> There are numerous congenital and acquired causes of thrombocytopenia. Thrombocytopenia could be a result of decreased bone marrow production, increased consumption, increased destruction, splenic sequestration or a combination of these causes. In this review, we have focused on some of the serious acquired causes of thrombocytopenia. There have been some significant advances in our understanding of the pathophysiology, diagnostic testing, and treatment of immune thrombocytopenia, heparin-induced thrombocytopenia, thrombotic thrombocytopenic purpura, and atypical hemolytic uremic syndrome over the past five years. These advances have resulted in a significant decrease in mortality and morbidity of patients with these disorders. Despite these advances, we are still faced with numerous unanswered questions in the pathophysiology and management of these complex thrombocytopenic disorders. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Thrombocytopenia, immune, heparin, thrombotic thrombocytopenic purpura, atypical hemolytic uremic </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Ravindra Sarode (<a href="mailto:ravi.sarode@utsouthwestern.edu">ravi.sarode@utsouthwestern.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Ravindra Sarode </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> RS is a consultant for Ablynx (Gent, Belgium). SN declares that he has no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2018 Nagalla S and Sarode R. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Nagalla S and Sarode R. Recent advances in understanding and management of acquired thrombocytopenia [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.12309.1" target=_blank>https://doi.org/10.12688/f1000research.12309.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 17 Jan 2018, <b>7</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.12309.1" target=_blank>https://doi.org/10.12688/f1000research.12309.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 17 Jan 2018, <b>7</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.12309.1" target=_blank>https://doi.org/10.12688/f1000research.12309.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d74286e158>Introduction</h2><p class="" id=d74286e161>There are numerous causes for thrombocytopenia, defined as a platelet count below 150 × 10<sup>9</sup>/L, and they could be broadly classified as congenital and acquired. Acquired thrombocytopenia could be immune or non-immune. Thrombocytopenia could be a result of decreased marrow production, increased destruction or sequestration/consumption in the periphery, or a combination of decreased production and sequestration. Initial steps in the evaluation of thrombocytopenia include review of the peripheral blood smear to exclude pseudo-thrombocytopenia due to platelet clumping. The peripheral blood smear may also provide clues toward other causes of thrombocytopenia when combined with the complete blood count and a good patient history and physical examination. Platelet size and presence of schistocytes, polychromasia, or spherocytes are some of the other features on the peripheral blood smear that help in diagnosing the etiology of thrombocytopenia. Thrombocytopenia could be a harbinger of a serious underlying medical condition such as thrombotic thrombocytopenic purpura (TTP) or heparin-induced thrombocytopenia (HIT). Therefore, it is always important for the treating physician to evaluate thrombocytopenia in a timely fashion so that the treatment for some of the serious conditions is not delayed. The current review will focus primarily on the recent updates in the pathophysiology and management of some of the serious acquired causes of thrombocytopenia encountered in the hospital setting (<a href="#T1">Table 1</a>).</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Recent advances in understanding and management of thrombocytopenia.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d74286e181 class=n-a></a><thead><a name=d74286e183 class=n-a></a><tr><a name=d74286e185 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d74286e187 class=n-a></a>Disease<br class=br>entity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d74286e192 class=n-a></a>Recent updates</th></tr></thead><tbody><a name=d74286e197 class=n-a></a><tr><a name=d74286e199 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e201 class=n-a></a>ITP</td><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e204 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;Absence of platelet-bound antibodies may predict non-response to rituximab.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;Patients with lower platelet counts and increased platelet reactivity have lower risk of bleeding.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;Multiple cycles of pulsed dexamethasone may result in higher long-term remission rates.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;Rituximab combined with high-dose dexamethasone in the first-line setting could result in higher response<br class=br>rates.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;Patients who are refractory to one of the TPO-RAs may respond to the other.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;Combining TPO-RA might be an option in refractory ITP.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;Recombinant thrombopoietin was safe and efficacious in pregnant patients.</td></tr><tr><a name=d74286e229 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e231 class=n-a></a>HIT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e234 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;Prerequisites for an immunogenic HIT antigen have been better understood.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;The atomic structure of the PF4-heparin complex has been defined.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;PF4 released from platelets during a bacterial infection can bind to the bacterial cell wall, resulting in a<br class=br>priming step for HIT.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;PF4-heparin complexes can activate, complement, and bind to the complement receptor 2 (CD21) on<br class=br>B cells to enhance antibody production.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;Spontaneous HIT developments in the absence of heparin exposure can occur after orthopedic<br class=br>procedures.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;Dynamic mechanical thromboprophylaxis may increase the incidence of HIT antibody formation.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;Low-molecular-weight heparin use instead of heparin results in significant cost savings due to the reduced<br class=br>incidence of HIT.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;&nbsp;&nbsp;Fondaparinux is safe and effective in the treatment of acute HIT.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;&nbsp;&nbsp;Accumulating evidence suggests safety and efficacy of direct oral anticoagulants in HIT.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;&nbsp;&nbsp;Refractory HIT with prolonged thrombocytopenia may benefit from intravenous immunoglobulin.</td></tr><tr><a name=d74286e276 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e278 class=n-a></a>TTP</td><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e281 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;Hyperbilirubinemia and plasma-free hemoglobin can falsely decrease ADAMTS13 activity in fluorescence<br class=br>resonance energy transfer (FRET) assay.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;Persistent ADAMTS13 activity of less than 10% within seven days of daily PLEX could be associated with<br class=br>worse outcomes.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;Upfront use of rituximab reduces exacerbation, refractoriness, number of PLEX sessions, and possibly<br class=br>hospital stay.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;Bortezomib is very promising in rituximab-refractory/relapsed TTP.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;Caplacizumab reverses pathophysiology instantly with a potential to reduce early mortality.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;ADAMTS13 activity of less than 10% alone is not sufficient for TTP relapse and requires another trigger.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;Cardiac and mesenteric ischemia is common.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;&nbsp;&nbsp;Delayed neurocognitive defects occur in some patients.</td></tr><tr><a name=d74286e314 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e316 class=n-a></a>aHUS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d74286e319 class=n-a></a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;Only about 60% of the patients have an identifiable genetic mutation.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;A modified Ham test can distinguish aHUS from TTP.<br class=br><br class=br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;The duration of eculizumab therapy is not clearly defined at the present time.</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d74286e333 class=n-a></a><p id=d74286e335> ADAMTS13, a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13; aHUS, atypical hemolytic uremic syndrome; HIT, heparin induced thrombocytopenia; ITP, immune thrombocytopenia; PF4, platelet factor 4; PLEX, plasma exchange; TPO-RA, thrombopoietin receptor agonist; TTP, thrombotic thrombocytopenic purpura.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d74286e344>Immune thrombocytopenia</h2><p class="" id=d74286e347>Most patients presenting with immune thrombocytopenia (ITP) either are asymptomatic or have minor muco-cutaneous bleeding. ITP remains a diagnosis of exclusion because there is no reliable diagnostic test to detect platelet autoantibodies<sup><a href="#ref-1">1</a></sup>. However, a rapid response to intravenous immunoglobulin (IVIG) or steroids, in addition to being therapeutic, might also aid in the diagnosis of ITP. Platelet autoantibodies or T cell-mediated autoimmunity or both play a role in the pathophysiology of ITP resulting in platelet destruction and reduced platelet production<sup><a href="#ref-2">2</a></sup>. Although platelet autoantibodies are not used in the diagnosis of ITP, recent work suggests that the lack of platelet-bound antibodies might predict non-responsiveness to rituximab therapy in patients with ITP<sup><a href="#ref-3">3</a></sup>. The bleeding phenotype varies significantly in patients with similar platelet counts and may be related to factors such as concomitant medications, age of the patient, and platelet reactivity. There is some evidence to suggest that ITP patients with lower platelet counts and increased platelet reactivity have a lower risk of bleeding<sup><a href="#ref-4">4</a></sup>. Intracranial hemorrhage is the most dreaded complication of ITP, and history of significant bleeding from other sites predicts for intracranial hemorrhage<sup><a href="#ref-5">5</a></sup>.</p><p class="" id=d74286e370>Steroids are the mainstay in the first-line treatment of ITP. A two- to four-week course of prednisone (1 mg/kg and taper) or four days of pulsed high-dose (40 mg daily) dexamethasone given every two to four weeks are the two commonly used steroid regimens<sup><a href="#ref-1">1</a></sup>. High-dose dexamethasone was found in one study to be more effective in inducing long-term remission compared with prednisone<sup><a href="#ref-6">6</a></sup>. Multiple cycles of pulsed dexamethasone may result in higher long-term remission rates compared with prednisone or a single cycle of dexamethasone<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup>. Two other retrospective studies showed conflicting results when comparing the efficacy of dexamethasone with that of prednisone<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Further prospective studies are needed to conclusively prove the efficacy of one steroid over the other. Given the convenience of a short-course, high-dose dexamethasone regimen over a longer duration of prednisone, we recommend high-dose dexamethasone over prednisone for the initial treatment of ITP<sup><a href="#ref-10">10</a></sup>. Treating physicians should be aware of the fact that a sustained response with high-dose dexamethasone might require multiple cycles of therapy, although some proportion of the patients might not achieve remission despite this approach. IVIG administered at a dose of 1 g/kg for one or two days is the other first-line treatment option<sup><a href="#ref-1">1</a></sup>. Given the faster platelet response to IVIG compared with steroids, IVIG is used in conjunction with steroids in patients with severe thrombocytopenia requiring urgent procedures or presenting with moderate to severe bleeding.</p><p class="" id=d74286e404>Before the advent of thrombopoietin receptor agonists (TPO-RAs), splenectomy and rituximab were the commonly used second-line agents. A recent single-center cohort study compared 83 splenectomized ITP patients with 83 non-splenectomized ITP patients. Splenectomy resulted in an overall response rate of 52% at 192 months<sup><a href="#ref-11">11</a></sup>. There was an increase in the venous thromboembolic events and serious infections resulting in hospitalization in the splenectomized population without a decrease in the overall survival. A recent population-matched cohort study demonstrated that splenectomized patients had a 50% overall increased five-year stroke risk compared with the disease-matched cohort (absolute risk 3% versus 2.3%) but that there was no increase in the five-year stroke risk in ITP patients undergoing splenectomy<sup><a href="#ref-12">12</a></sup>. Another recent large single-center study confirmed the curative nature of splenectomy in more than 50% of the patients undergoing the procedure, and corticosteroid dependence predicted for sustained response after splenectomy<sup><a href="#ref-13">13</a></sup>. Taking into consideration the high cure rates and the opportunity to avoid long-term medications, we recommend considering splenectomy as the initial second-line treatment option in young steroid-dependent ITP patients.</p><p class="" id=d74286e419>Rituximab, an anti-CD20 monoclonal antibody, can result in 50 to 60% initial response rates, although only about 20% of the patients maintain the response at five years<sup><a href="#ref-14">14</a></sup>. A recent randomized control trial comparing rituximab with placebo demonstrated no difference in the complete remission rates between the two arms at 18 months<sup><a href="#ref-15">15</a></sup>. Rituximab, when combined with one to three cycles of high-dose dexamethasone in a first-line setting, could result in higher response rates than dexamethasone alone<sup><a href="#ref-16">16</a>–<a href="#ref-18">18</a></sup>.</p><p class="" id=d74286e438>Two TPO-RAs, romiplostim and eltrombopag, were initially used in the third-line setting but have rapidly moved up the ladder to second-line status. These agents have transformed the management for ITP. Long-term follow-up of these agents has demonstrated that they are highly effective and safe in the treatment of patients with ITP<sup><a href="#ref-19">19</a>–<a href="#ref-21">21</a></sup>. TPO-RA could also be used in the first-line setting, in conjunction with steroids and IVIG, to treat severe thrombocytopenia and significant bleeding. There is small proportion of patients who are refractory to one of the agents but may respond to the other<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. There is also some experience in combining the two agents, given their different target sites on the thrombopoietin receptor, in patients refractory to single-agent, second-line therapy<sup><a href="#ref-23">23</a></sup>. TPO-RA could also be used in combination with other immunosuppressive therapies to improve the response rates in refractory ITP patients<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d74286e463>Although ITP in pregnancy can generally be treated with steroids and IVIG, there is an occasional need for other effective therapies when the patients do not respond to the first-line agents. A recent study showed that recombinant thrombopoietin was safe and efficacious in increasing the platelet count in 31 pregnant women with ITP<sup><a href="#ref-25">25</a></sup>. Unlike the previously studied pegylated human recombinant megakaryocytic growth and development factor (PEG-rHuMGDF), which resulted in the formation of anti-thrombopoietin antibodies<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>, the new recombinant and glycosylated form of thrombopoietin was similar to endogenous thrombopoietin, and anti-thrombopoietin antibodies were not detected in the limited sample size of patients. These pregnant females with ITP were refractory to the first-line therapy of steroids or IVIG (or both) with some signs and symptoms of bleeding and platelet counts of less than 30 × 10<sup>9</sup>/L. About 75% of patients responded with platelet counts increasing to 30–100 × 10<sup>9</sup>/L or more than 100 × 10<sup>9</sup>/L. TPO-RA and recombinant thrombopoietin might have an important role in the management of pregnant refractory ITP patients.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d74286e489>Heparin-induced thrombocytopenia</h2><p class="" id=d74286e492>Despite the widespread use of direct oral anticoagulants (DOACs) and other parenteral anticoagulants, unfractionated heparin (UFH) still plays an important role in the management of hospitalized patients. Hence, understanding the pathophysiology and management of HIT is still very relevant to the treating physician<sup><a href="#ref-28">28</a></sup>. HIT is a disease of multiple paradoxes. It is a disease in which an anticoagulant causes thrombosis and thrombocytopenia is associated with thrombosis rather than bleeding. In HIT, unlike in other thrombocytopenias, platelet transfusions increase the risk of clotting. Simply stopping the offending agent (heparin) is not adequate treatment unlike other drug-induced thrombocytopenias and vitamin K antagonists anticoagulant is contraindicated in the treatment of acute HIT.</p><p class="" id=d74286e499>HIT antibodies are induced by platelet factor 4 (PF4)-heparin or endogenous glycosaminoglycan complexes. A subset of these IgG antibodies can cross-link Fcγ receptor IIA (FcRγIIA), causing platelet and monocyte activation that results in consumptive thrombocytopenia and venous and/or arterial thrombosis<sup><a href="#ref-29">29</a></sup>. There are multiple prerequisites for an immunogenic HIT antigen. The immunogenicity depends on distinct stoichiometric ratios of PF4-heparin complexes, and the complexes reach a size of more than 670 kDa by charge neutralization. Immunogenic polyanions with anti-parallel beta-sheet content of more than 30% and an energy release of more than 4,000 calories per molPF4 for effective antibody binding are the other prerequisites<sup><a href="#ref-30">30</a>,<a href="#ref-31">31</a></sup>. The atomic structure of the PF4-heparin complex was worked out in 2015, although the synthetic pentasaccharide, fondaparinux, was used in the complex instead of heparin<sup><a href="#ref-32">32</a></sup>. PF4 released from platelets during a bacterial infection can bind to the bacterial cell wall, resulting in a priming step that could result in the formation of antibodies against PF4-heparin complex when exposed to heparin at a later time<sup><a href="#ref-33">33</a></sup>. PF4-heparin complexes can activate complement and bind to the complement receptor 2 (CD21) on B cells, enhancing the antibody production<sup><a href="#ref-34">34</a></sup>. A better understanding of the HIT pathophysiology would lead to the development of better diagnostic tests and effective anticoagulants to treat the condition.</p><p class="" id=d74286e525>Spontaneous HIT develops in the absence of exposure to any heparin and is common in patients undergoing orthopedic procedures<sup><a href="#ref-35">35</a></sup>. The tissue damage as a result of total hip or knee arthroplasty can lead to platelet activation, polyanion release, and formation of PF4-polyanion complexes. Dynamic mechanical thromboprophylaxis might add to the tissue damage, platelet activation, and polyanion release, increasing the incidence of HIT antibody formation<sup><a href="#ref-36">36</a></sup>. In the setting of total knee arthroplasty, the incidence of HIT antibody formation was similar in patients receiving dynamic mechanical thromboprophylaxis with or without heparin/fondaparinux. Since they were identified by enzyme-linked immunosorbent assay (ELISA), it is not clear whether these antibodies are platelet-activating.</p><p class="" id=d74286e536>Reducing the incidence of HIT with the use of low-molecular-weight heparins (LMWHs) instead of UFH results in significant cost savings with an ‘avoid heparin’ protocol<sup><a href="#ref-37">37</a></sup>. Although the pharmacy-and-therapeutics committee of many hospitals prefers UFH over LMWH for venous thromboembolism prophylaxis because of the cost differential between the two drugs, a single case of complicated HIT with thrombosis can wipe out all the upfront cost savings.</p><p class="" id=d74286e544>Fondaparinux is safe and effective in the treatment of acute HIT<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>. The time taken to achieve therapeutic levels, less risk of bleeding, and shorter hospital stay resulting in cost savings are some of the advantages of fondaparinux over argatroban. We recommend fondaparinux over parenteral direct thrombin inhibitors in the treatment of acute HIT in patients who are not critically ill and have good renal function. There is accumulating evidence for the safety and efficacy of DOACs in the treatment of HIT<sup><a href="#ref-40">40</a>,<a href="#ref-41">41</a></sup>. These medications, like fondaparinux, would definitely help with reducing the length of hospital stay and patient convenience. Until there are more data, we do not recommend DOACs in the initial treatment of acute HIT, but they could be used in patients after platelet recovery.</p><p class="" id=d74286e561>A small proportion of patients with HIT might have refractory disease with prolonged thrombocytopenia despite therapeutic anticoagulation. IVIG could be used in conjunction with anticoagulation to help with platelet recovery<sup><a href="#ref-42">42</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d74286e571>Thrombotic thrombocytopenic purpura</h2><p class="" id=d74286e574>Microangiopathic hemolytic anemia (MAHA) and thrombocytopenia are a common denominator in multiple disease states. Of these, TTP is the easiest to diagnose since it is caused by a severe ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 or von Willebrand cleaving protease) deficiency (&lt;10%)<sup><a href="#ref-43">43</a></sup>. TTP could be acquired due to autoantibodies to ADAMTS13 or congenital due to severe deficiency of ADAMTS13. We recommend testing for ADAMTS13 in every patient with MAHA and thrombocytopenia when TTP is part of the differential diagnosis, although treatment of TTP should not be delayed while awaiting the results<sup><a href="#ref-44">44</a></sup>. Sepsis and cirrhosis can decrease ADAMTS13 activity but generally not less than 10%<sup><a href="#ref-43">43</a></sup>. Hyperbilirubinemia (&gt;10 mg/dL) and free plasma hemoglobin, however, could give falsely deficient levels (&lt;10%) due to interference in the fluorescence resonance energy transfer (FRET) assay<sup><a href="#ref-43">43</a>,<a href="#ref-45">45</a></sup>. IgG antibodies against ADAMTS13 are detected in 75–80% of the patients by the functional Bethesda method in acquired TTP; however, remaining patients may have non-neutralizing antibodies often detected by an ELISA<sup><a href="#ref-46">46</a></sup>. Because ADAMTS13 assay is often sent to a reference laboratory, most patients with unexplained MAHA and thrombocytopenia are started on plasma exchange (PLEX). If the ADMTS13 is more than 10%, PLEX should be discontinued and other causes of MAHA and thrombocytopenia should be investigated for appropriate treatment such as metastatic malignancy, malignant hypertension, and atypical hemolytic uremic syndrome (aHUS)<sup><a href="#ref-44">44</a></sup>. The blood for ADAMTS13 testing should preferably be drawn prior to instituting PLEX, although levels are often low in acquired TTP even after a couple of days of PLEX<sup><a href="#ref-47">47</a></sup>. Not achieving ADAMTS13 activity levels of more than 10% within seven days of instituting daily PLEX could be associated with worse outcomes<sup><a href="#ref-47">47</a></sup>.</p><p class="" id=d74286e613>PLEX should be started as soon as the clinical diagnosis of TTP is made. The currently available plasma preparations are all equivalent in terms of their outcomes in TTP<sup><a href="#ref-48">48</a></sup>. Glucocorticoids are often started simultaneously. Once the diagnosis is confirmed to be autoimmune TTP, rituximab is routinely used in the treatment of relapsed or refractory TTP patients. However, there is evidence to support upfront use of rituximab in acute TTP to reduce exacerbation, refractoriness, number of PLEX sessions, and possibly hospital stay<sup><a href="#ref-46">46</a></sup>. Although this approach might result in overtreatment of half of the patients with TTP, the decreased morbidity and mortality in patients with refractory or relapsed TTP would outweigh the overtreatment issue. Most physicians use rituximab 375 mg/m<sup>2</sup> weekly for four doses, although our personal experience with a lower dose of rituximab at 100 mg weekly for four doses appears promising. There is a clinical trial under way to study the efficacy of low-dose rituximab (ClinicalTrials.gov Identifier: NCT01554514). Bortezomib is very promising as an adjunct to PLEX in the treatment of refractory or relapsed acquired TTP or both<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. We recommend using bortezomib in refractory and/or relapsed TTP patients who do not respond to rituximab. Daily subcutaneous caplacizumab, a nanobody against von Willebrand factor (VWF) A-1 domain preventing its interaction with GPIb on platelets, resulted in faster platelet responses in acute TTP compared with a placebo when used along with PLEX<sup><a href="#ref-51">51</a></sup>. This nanobody is not a cure; however, by preventing the interaction between VWF and platelets, it causes rapid reversal of the underlying pathogenetic mechanism, resulting in a potential to reduce early mortality. The drug is being studied further in a phase 3 trial.</p><p class="" id=d74286e638>Some patients achieving clinical remission may have ADAMTS13 activity of less than 10%. Nonetheless, ADAMTS13 activity of less than 10% alone is not sufficient for TTP relapse and requires a trigger such as infection, pregnancy, or concomitant inflammatory conditions increasing VWF levels<sup><a href="#ref-52">52</a></sup>. Although measuring ADAMTS13 activity during remission and preemptively treating with rituximab for moderately to severely low ADAMTS13 activity is a commonly used approach at some institutions, this practice needs further evaluation. We recommend following these patients carefully because of the higher rate of TTP recurrence in this population. Since this is a very episodic disease, education of patients for signs and symptoms of relapse is a crucial part of the management plan. In addition to the neurological and renal manifestations, TTP could result in cardiac and mesenteric ischemia<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. Patients could commonly have elevated cardiac troponin without any clinical cardiac abnormalities<sup><a href="#ref-53">53</a></sup>. Similarly, long-term neurocognitive defects are recognized in patients with TTP<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d74286e666>Atypical hemolytic uremic syndrome</h2><p class="" id=d74286e669>aHUS results from a dysregulated complement system, leading to cell and tissue damage<sup><a href="#ref-57">57</a></sup>. Although MAHA, thrombocytopenia, and oliguric renal failure are the three common presenting features, aHUS is a systemic disease that can involve any organ system. aHUS, unlike Shiga toxin-producing <i>Escherichia coli</i> HUS, does not present with the prodrome of bloody diarrhea and often is recurrent. Mutations in the genes encoding for complement proteins, complement regulatory factors, or autoantibodies to complement factors, when combined with another stressor such as infection or surgery, often result in the development of aHUS. Only about 60% of patients with aHUS have an identifiable genetic mutation<sup><a href="#ref-58">58</a></sup>. Mutations in the gene encoding for factor H are the most common among patients with aHUS. The other defects involve mutations in CD46, factor I, <i>C3</i>, factor B, thrombomodulin, diacylglycerol kinase ε, and CFHR1/3 deficiency with anti-factor H autoantibodies. Since mutation testing and screening for antibodies to complement proteins are not available readily, diagnosis of aHUS is usually made on the basis of clinical features and an ADAMTS13 activity of more than 10%. A modified Ham test has shown some promise in distinguishing aHUS and TTP serum samples<sup><a href="#ref-59">59</a></sup>. Genetic mutations or the autoantibodies in aHUS result in the activation of alternate pathway (AP); when <i>PIGA</i> null TF-1 cells (PNH-like cells) are added to the serum samples, aHUS serum samples result in a positive test (cell death) because of the activated AP compared with the TTP samples.</p><p class="" id=d74286e694>If TTP is in the differential diagnosis, PLEX is started until ADAMTS13 activity results. But if the presenting features are classic for aHUS or if the ADAMTS13 activity is more than 10%, the appropriate management would be to start eculizumab, an anti-C5 antibody, immediately. Eculizumab is effective in improving renal function and platelet count and halting tissue damage from the AP activation<sup><a href="#ref-60">60</a></sup>. The optimal duration of eculizumab therapy in aHUS is not clearly defined at the present time<sup><a href="#ref-61">61</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d74286e709>Conclusions</h2><p class="" id=d74286e712>In summary, acute thrombocytopenia is a common clinical presenting feature in many serious hematological conditions. There have been some significant advances in our understanding of the pathophysiology, diagnostic testing, and treatment of these disorders over the past five years (<a href="#T1">Table 1</a>). Unfortunately, ITP remains a diagnosis of exclusion; however, there are many newer treatment options available for ITP, drastically improving the outcome of patients with ITP. Similarly, we have a better understanding of HIT pathophysiology, and this is paving the way for development of better diagnostic and therapeutic options for HIT, including IVIG. Availability of drugs such as caplacizumab would help in preventing early deaths due to rapid reversal of pathophysiology of TTP. B lymphocyte- and plasma cell-directed therapies have improved the response rates in refractory TTP and decreased the relapses. Finally, the use of eculizumab in complement-mediated aHUS has significantly decreased morbidity and mortality.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d74286e1 class=n-a></a><h2 class=main-title id=d74484>Competing interests</h2><p class=metadata-entry><a name=d74286e95 class=n-a></a><p id=d74286e96> RS is a consultant for Ablynx (Gent, Belgium). SN declares that he has no competing interests. </p></p></div><div class=back-section><a name=d74286e1 class=n-a></a><h2 class=main-title id=d74486>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d74286e722 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d74685>References</h2><div class="section ref-list"><a name=d74286e722 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718390789"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e729 class=n-a></a>Neunert C, Lim W, Crowther M, <i> et al.</i>: The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. <i>Blood.</i> 2011; <b>117</b>(16): 4190–207. <a target=xrefwindow id=d74286e740 href="http://www.ncbi.nlm.nih.gov/pubmed/21325604">PubMed Abstract </a> | <a target=xrefwindow id=d74286e743 href="http://dx.doi.org/10.1182/blood-2010-08-302984">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718390789">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d74286e756 class=n-a></a>Cines DB, Cuker A, Semple JW: Pathogenesis of immune thrombocytopenia. <i>Presse Med.</i> 2014; <b>43</b>(4 Pt 2): e49–59. <a target=xrefwindow id=d74286e764 href="http://www.ncbi.nlm.nih.gov/pubmed/24630266">PubMed Abstract </a> | <a target=xrefwindow id=d74286e767 href="http://dx.doi.org/10.1016/j.lpm.2014.01.010">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732412997"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e776 class=n-a></a>Porcelijn L, Huiskes E, Schipperus M, <i> et al.</i>: Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients. <i>Blood.</i> 2017; <b>129</b>(25): 3389–91. <a target=xrefwindow id=d74286e787 href="http://www.ncbi.nlm.nih.gov/pubmed/28468795">PubMed Abstract </a> | <a target=xrefwindow id=d74286e790 href="http://dx.doi.org/10.1182/blood-2016-11-751719">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732412997">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726346320"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e803 class=n-a></a>Middelburg RA, Carbaat-Ham JC, Hesam H, <i> et al.</i>: Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk. <i>Hematology.</i> 2016; <b>21</b>(9): 549–51. <a target=xrefwindow id=d74286e814 href="http://www.ncbi.nlm.nih.gov/pubmed/27159138">PubMed Abstract </a> | <a target=xrefwindow id=d74286e817 href="http://dx.doi.org/10.1080/10245332.2016.1180097">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726346320">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726652422"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e830 class=n-a></a>Melboucy-Belkhir S, Khellaf M, Augier A, <i> et al.</i>: Risk factors associated with intracranial hemorrhage in adults with immune thrombocytopenia: A study of 27 cases. <i>Am J Hematol.</i> 2016; <b>91</b>(12): E499–E501. <a target=xrefwindow id=d74286e841 href="http://www.ncbi.nlm.nih.gov/pubmed/27528011">PubMed Abstract </a> | <a target=xrefwindow id=d74286e844 href="http://dx.doi.org/10.1002/ajh.24529">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726652422">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726367827"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e858 class=n-a></a>Matschke J, Müller-Beissenhirtz H, Novotny J, <i> et al.</i>: A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study. <i>Acta Haematol.</i> 2016; <b>136</b>(2): 101–7. <a target=xrefwindow id=d74286e869 href="http://www.ncbi.nlm.nih.gov/pubmed/27189086">PubMed Abstract </a> | <a target=xrefwindow id=d74286e872 href="http://dx.doi.org/10.1159/000445420">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726367827">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725860857"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e885 class=n-a></a>Wei Y, Ji XB, Wang YW, <i> et al.</i>: High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial. <i>Blood.</i> 2016; <b>127</b>(3): 296–302; quiz 370. <a target=xrefwindow id=d74286e896 href="http://www.ncbi.nlm.nih.gov/pubmed/26480931">PubMed Abstract </a> | <a target=xrefwindow id=d74286e899 href="http://dx.doi.org/10.1182/blood-2015-07-659656">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725860857">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d74286e912 class=n-a></a>Nakazaki K, Hosoi M, Hangaishi A, <i> et al.</i>: Comparison between pulsed high-dose dexamethasone and daily corticosteroid therapy for adult primary immune thrombocytopenia: a retrospective study. <i>Intern Med.</i> 2012; <b>51</b>(8): 859–63. <a target=xrefwindow id=d74286e923 href="http://www.ncbi.nlm.nih.gov/pubmed/22504239">PubMed Abstract </a> | <a target=xrefwindow id=d74286e926 href="http://dx.doi.org/10.2169/internalmedicine.51.7005">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d74286e935 class=n-a></a>Sakamoto K, Nakasone H, Tsurumi S, <i> et al.</i>: Prednisone versus high-dose dexamethasone for untreated primary immune thrombocytopenia. A retrospective study of the Japan Hematology &amp; Oncology Clinical Study Group. <i>J Thromb Thrombolysis.</i> 2014; <b>37</b>(3): 279–86. <a target=xrefwindow id=d74286e946 href="http://www.ncbi.nlm.nih.gov/pubmed/23686644">PubMed Abstract </a> | <a target=xrefwindow id=d74286e949 href="http://dx.doi.org/10.1007/s11239-013-0939-3">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726779213"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e958 class=n-a></a>Mithoowani S, Gregory-Miller K, Goy J, <i> et al.</i>: High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. <i>Lancet Haematol.</i> 2016; <b>3</b>(10): e489–e496. <a target=xrefwindow id=d74286e969 href="http://www.ncbi.nlm.nih.gov/pubmed/27658982">PubMed Abstract </a> | <a target=xrefwindow id=d74286e972 href="http://dx.doi.org/10.1016/S2352-3026(16)30109-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726779213">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727093378"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e985 class=n-a></a>Thai LH, Mahévas M, Roudot-Thoraval F, <i> et al.</i>: Long-term complications of splenectomy in adult immune thrombocytopenia. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(48): e5098. <a target=xrefwindow id=d74286e996 href="http://www.ncbi.nlm.nih.gov/pubmed/27902585">PubMed Abstract </a> | <a target=xrefwindow id=d74286e999 href="http://dx.doi.org/10.1097/MD.0000000000005098">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1003 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5134764">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727093378">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727681351"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1017 class=n-a></a>Rørholt M, Ghanima W, Farkas DK, <i> et al.</i>: Risk of cardiovascular events and pulmonary hypertension following splenectomy - a Danish population-based cohort study from 1996–2012. <i>Haematologica.</i> 2017; <b>102</b>(8): 1333–41. <a target=xrefwindow id=d74286e1028 href="http://www.ncbi.nlm.nih.gov/pubmed/28572164">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1031 href="http://dx.doi.org/10.3324/haematol.2016.157008">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1035 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5541868">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727681351">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726858948"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1048 class=n-a></a>Guan Y, Wang S, Xue F, <i> et al.</i>: Long-term results of splenectomy in adult chronic immune thrombocytopenia. <i>Eur J Haematol.</i> 2017; <b>98</b>(3): 235–41. <a target=xrefwindow id=d74286e1059 href="http://www.ncbi.nlm.nih.gov/pubmed/27753191">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1062 href="http://dx.doi.org/10.1111/ejh.12821">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726858948">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726028959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1075 class=n-a></a>Chugh S, Darvish-Kazem S, Lim W, <i> et al.</i>: Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. <i>Lancet Haematol.</i> 2015; <b>2</b>(2): e75–81. <a target=xrefwindow id=d74286e1086 href="http://www.ncbi.nlm.nih.gov/pubmed/26687612">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1089 href="http://dx.doi.org/10.1016/S2352-3026(15)00003-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726028959">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725347054"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1102 class=n-a></a>Ghanima W, Khelif A, Waage A, <i> et al.</i>: Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial. <i>Lancet.</i> 2015; <b>385</b>(9978): 1653–61. <a target=xrefwindow id=d74286e1113 href="http://www.ncbi.nlm.nih.gov/pubmed/25662413">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1116 href="http://dx.doi.org/10.1016/S0140-6736(14)61495-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725347054">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717976348"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1129 class=n-a></a>Gudbrandsdottir S, Birgens HS, Frederiksen H, <i> et al.</i>: Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed patients with primary immune thrombocytopenia. <i>Blood.</i> 2013; <b>121</b>(11): 1976–81. <a target=xrefwindow id=d74286e1140 href="http://www.ncbi.nlm.nih.gov/pubmed/23293082">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1143 href="http://dx.doi.org/10.1182/blood-2012-09-455691">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717976348">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718390801"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1156 class=n-a></a>Zaja F, Baccarani M, Mazza P, <i> et al.</i>: Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. <i>Blood.</i> 2010; <b>115</b>(14): 2755–62. <a target=xrefwindow id=d74286e1167 href="http://www.ncbi.nlm.nih.gov/pubmed/20130241">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1170 href="http://dx.doi.org/10.1182/blood-2009-07-229815">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718390801">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726379259"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1184 class=n-a></a>Chapin J, Lee CS, Zhang H, <i> et al.</i>: Gender and duration of disease differentiate responses to rituximab-dexamethasone therapy in adults with immune thrombocytopenia. <i>Am J Hematol.</i> 2016; <b>91</b>(9): 907–11. <a target=xrefwindow id=d74286e1195 href="http://www.ncbi.nlm.nih.gov/pubmed/27220625">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1198 href="http://dx.doi.org/10.1002/ajh.24434">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726379259">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725669721"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1211 class=n-a></a>Cines DB, Gernsheimer T, Wasser J, <i> et al.</i>: Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim. <i>Int J Hematol.</i> 2015; <b>102</b>(3): 259–70. <a target=xrefwindow id=d74286e1222 href="http://www.ncbi.nlm.nih.gov/pubmed/26201709">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1225 href="http://dx.doi.org/10.1007/s12185-015-1837-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725669721">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726697328"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1238 class=n-a></a>Elgebaly AS, Ashal GE, Elfil M, <i> et al.</i>: Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled Trials. <i>Clin Appl Thromb Hemost.</i> 2017; <b>23</b>(8): 928–37. <a target=xrefwindow id=d74286e1249 href="http://www.ncbi.nlm.nih.gov/pubmed/27572890">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1252 href="http://dx.doi.org/10.1177/1076029616663849">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726697328">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732006011"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1265 class=n-a></a>Wong RSM, Saleh MN, Khelif A, <i> et al.</i>: Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study. <i>Blood.</i> 2017; <b>130</b>(23): 2527–2536. <a target=xrefwindow id=d74286e1276 href="http://www.ncbi.nlm.nih.gov/pubmed/29042367">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1279 href="http://dx.doi.org/10.1182/blood-2017-04-748707">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732006011">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d74286e1292 class=n-a></a>Khellaf M, Viallard JF, Hamidou M, <i> et al.</i>: A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia. <i>Haematologica.</i> 2013; <b>98</b>(6): 881–7. <a target=xrefwindow id=d74286e1303 href="http://www.ncbi.nlm.nih.gov/pubmed/23445876">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1306 href="http://dx.doi.org/10.3324/haematol.2012.074633">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1310 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3669443">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d74286e1319 class=n-a></a>Kuter DJ, Macahilig C, Grotzinger KM, <i> et al.</i>: Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim. <i>Int J Hematol.</i> 2015; <b>101</b>(3): 255–63. <a target=xrefwindow id=d74286e1330 href="http://www.ncbi.nlm.nih.gov/pubmed/25586660">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1333 href="http://dx.doi.org/10.1007/s12185-014-1731-7">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726470560"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1343 class=n-a></a>Mahévas M, Gerfaud-Valentin M, Moulis G, <i> et al.</i>: Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia. <i>Blood.</i> 2016; <b>128</b>(12): 1625–30. <a target=xrefwindow id=d74286e1354 href="http://www.ncbi.nlm.nih.gov/pubmed/27354722">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1357 href="http://dx.doi.org/10.1182/blood-2016-03-704734">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726470560">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727734841"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1370 class=n-a></a>Kong Z, Qin P, Xiao S, <i> et al.</i>: A novel recombinant human thrombopoietin therapy for the management of immune thrombocytopenia in pregnancy. <i>Blood.</i> 2017; <b>130</b>(9): 1097–1103. <a target=xrefwindow id=d74286e1381 href="http://www.ncbi.nlm.nih.gov/pubmed/28630121">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1384 href="http://dx.doi.org/10.1182/blood-2017-01-761262">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727734841">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d74286e1397 class=n-a></a>Basser RL, O'Flaherty E, Green M, <i> et al.</i>: Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. <i>Blood.</i> 2002; <b>99</b>(7): 2599–602. <a target=xrefwindow id=d74286e1408 href="http://www.ncbi.nlm.nih.gov/pubmed/11895799">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1411 href="http://dx.doi.org/10.1182/blood.V99.7.2599">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d74286e1420 class=n-a></a>Li J, Yang C, Xia Y, <i> et al.</i>: Thrombocytopenia caused by the development of antibodies to thrombopoietin. <i>Blood.</i> 2001; <b>98</b>(12): 3241–8. <a target=xrefwindow id=d74286e1431 href="http://www.ncbi.nlm.nih.gov/pubmed/11719360">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1434 href="http://dx.doi.org/10.1182/blood.V98.12.3241">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d74286e1443 class=n-a></a>Onwuemene O, Arepally GM: Heparin-induced thrombocytopenia: research and clinical updates. <i>Hematology Am Soc Hematol Educ Program.</i> 2016; <b>2016</b>(1): 262–8. <a target=xrefwindow id=d74286e1451 href="http://www.ncbi.nlm.nih.gov/pubmed/27913490">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1454 href="http://dx.doi.org/10.1182/asheducation-2016.1.262">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725893577"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1463 class=n-a></a>Tutwiler V, Madeeva D, Ahn HS, <i> et al.</i>: Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. <i>Blood.</i> 2016; <b>127</b>(4): 464–72. <a target=xrefwindow id=d74286e1474 href="http://www.ncbi.nlm.nih.gov/pubmed/26518435">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1477 href="http://dx.doi.org/10.1182/blood-2013-11-539262">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1481 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4731847">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725893577">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d74286e1495 class=n-a></a>Brandt S, Krauel K, Gottschalk KE, <i> et al.</i>: Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity. <i>Thromb Haemost.</i> 2014; <b>112</b>(1): 53–64. <a target=xrefwindow id=d74286e1506 href="http://www.ncbi.nlm.nih.gov/pubmed/24671506">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1509 href="http://dx.doi.org/10.1160/TH13-08-0634">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d74286e1518 class=n-a></a>Kreimann M, Brandt S, Krauel K, <i> et al.</i>: Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. <i>Blood.</i> 2014; <b>124</b>(15): 2442–9. <a target=xrefwindow id=d74286e1529 href="http://www.ncbi.nlm.nih.gov/pubmed/25150299">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1532 href="http://dx.doi.org/10.1182/blood-2014-03-559518">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d74286e1541 class=n-a></a>Cai Z, Yarovoi SV, Zhu Z, <i> et al.</i>: Atomic description of the immune complex involved in heparin-induced thrombocytopenia. <i>Nat Commun.</i> 2015; <b>6</b>: 8277. <a target=xrefwindow id=d74286e1552 href="http://www.ncbi.nlm.nih.gov/pubmed/26391892">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1555 href="http://dx.doi.org/10.1038/ncomms9277">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1559 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4580983">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9384959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1568 class=n-a></a>Krauel K, Pötschke C, Weber C, <i> et al.</i>: Platelet factor 4 binds to bacteria, [corrected] inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. <i>Blood.</i> 2011; <b>117</b>(4): 1370–8. <a target=xrefwindow id=d74286e1579 href="http://www.ncbi.nlm.nih.gov/pubmed/20959601">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1582 href="http://dx.doi.org/10.1182/blood-2010-08-301424">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9384959">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726505450"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1595 class=n-a></a>Khandelwal S, Lee GM, Hester CG, <i> et al.</i>: The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21). <i>Blood.</i> 2016; <b>128</b>(14): 1789–99. <a target=xrefwindow id=d74286e1606 href="http://www.ncbi.nlm.nih.gov/pubmed/27412887">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1609 href="http://dx.doi.org/10.1182/blood-2016-04-709634">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1613 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5054694">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726505450">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d74286e1626 class=n-a></a>Warkentin TE, Basciano PA, Knopman J, <i> et al.</i>: Spontaneous heparin-induced thrombocytopenia syndrome: 2 new cases and a proposal for defining this disorder. <i>Blood.</i> 2014; <b>123</b>(23): 3651–4. <a target=xrefwindow id=d74286e1637 href="http://www.ncbi.nlm.nih.gov/pubmed/24677540">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1640 href="http://dx.doi.org/10.1182/blood-2014-01-549741">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726008124"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1650 class=n-a></a>Bito S, Miyata S, Migita K, <i> et al.</i>: Mechanical prophylaxis is a heparin-independent risk for anti-platelet factor 4/heparin antibody formation after orthopedic surgery. <i>Blood.</i> 2016; <b>127</b>(8): 1036–43. <a target=xrefwindow id=d74286e1661 href="http://www.ncbi.nlm.nih.gov/pubmed/26659923">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1664 href="http://dx.doi.org/10.1182/blood-2015-06-651620">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1668 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4768427">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726008124">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726105714"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1681 class=n-a></a>McGowan KE, Makari J, Diamantouros A, <i> et al.</i>: Reducing the hospital burden of heparin-induced thrombocytopenia: impact of an avoid-heparin program. <i>Blood.</i> 2016; <b>127</b>(16): 1954–9. <a target=xrefwindow id=d74286e1692 href="http://www.ncbi.nlm.nih.gov/pubmed/26817956">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1695 href="http://dx.doi.org/10.1182/blood-2015-07-660001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726105714">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725281411"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1708 class=n-a></a>Kang M, Alahmadi M, Sawh S, <i> et al.</i>: Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. <i>Blood.</i> 2015; <b>125</b>(6): 924–9. <a target=xrefwindow id=d74286e1719 href="http://www.ncbi.nlm.nih.gov/pubmed/25515959">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1722 href="http://dx.doi.org/10.1182/blood-2014-09-599498">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725281411">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d74286e1735 class=n-a></a>Warkentin TE: How I diagnose and manage HIT. <i>Hematology Am Soc Hematol Educ Program.</i> 2011; <b>2011</b>(1): 143–9. <a target=xrefwindow id=d74286e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/22160026">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1746 href="http://dx.doi.org/10.1182/asheducation-2011.1.143">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727779026"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1755 class=n-a></a>Davis KA, Davis DO: Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia. <i>Eur J Haematol.</i> 2017; <b>99</b>(4): 332–5. <a target=xrefwindow id=d74286e1763 href="http://www.ncbi.nlm.nih.gov/pubmed/28672052">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1766 href="http://dx.doi.org/10.1111/ejh.12921">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727779026">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727749780"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1779 class=n-a></a>Warkentin TE, Pai M, Linkins LA: Direct oral anticoagulants for treatment of HIT: update of Hamilton experience and literature review. <i>Blood.</i> 2017; <b>130</b>(9): 1104–13. <a target=xrefwindow id=d74286e1787 href="http://www.ncbi.nlm.nih.gov/pubmed/28646118">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1790 href="http://dx.doi.org/10.1182/blood-2017-04-778993">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727749780">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727540376"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1804 class=n-a></a>Padmanabhan A, Jones CG, Pechauer SM, <i> et al.</i>: IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia. <i>Chest.</i> 2017; <b>152</b>(3): 478–85. <a target=xrefwindow id=d74286e1815 href="http://www.ncbi.nlm.nih.gov/pubmed/28427966">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1818 href="http://dx.doi.org/10.1016/j.chest.2017.03.050">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727540376">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d74286e1831 class=n-a></a>Sadler JE: What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura. <i>Hematology Am Soc Hematol Educ Program.</i> 2015; <b>2015</b>(1): 631–6. <a target=xrefwindow id=d74286e1839 href="http://www.ncbi.nlm.nih.gov/pubmed/26637781">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1842 href="http://dx.doi.org/10.1182/asheducation-2015.1.631">Publisher Full Text </a> | <a target=xrefwindow id=d74286e1845 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4777280">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d74286e1854 class=n-a></a>Shah N, Rutherford C, Matevosyan K, <i> et al.</i>: Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). <i>Br J Haematol.</i> 2013; <b>163</b>(4): 514–9. <a target=xrefwindow id=d74286e1865 href="http://www.ncbi.nlm.nih.gov/pubmed/24111495">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1868 href="http://dx.doi.org/10.1111/bjh.12569">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d74286e1877 class=n-a></a>Meyer SC, Sulzer I, Lämmle B, <i> et al.</i>: Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. <i>J Thromb Haemost.</i> 2007; <b>5</b>(4): 866–7. <a target=xrefwindow id=d74286e1888 href="http://www.ncbi.nlm.nih.gov/pubmed/17408415">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1891 href="http://dx.doi.org/10.1111/j.1538-7836.2007.02438.x">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d74286e1900 class=n-a></a>Joly BS, Coppo P, Veyradier A: Thrombotic thrombocytopenic purpura. <i>Blood.</i> 2017; <b>129</b>(21): 2836–46. <a target=xrefwindow id=d74286e1908 href="http://www.ncbi.nlm.nih.gov/pubmed/28416507">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1911 href="http://dx.doi.org/10.1182/blood-2016-10-709857">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d74286e1920 class=n-a></a>Wu N, Liu J, Yang S, <i> et al.</i>: Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura. <i>Transfusion.</i> 2015; <b>55</b>(1): 18–24. <a target=xrefwindow id=d74286e1931 href="http://www.ncbi.nlm.nih.gov/pubmed/24953079">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1934 href="http://dx.doi.org/10.1111/trf.12762">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d74286e1944 class=n-a></a>Toussaint-Hacquard M, Coppo P, Soudant M, <i> et al.</i>: Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study. <i>Transfusion.</i> 2015; <b>55</b>(10): 2445–51. <a target=xrefwindow id=d74286e1955 href="http://www.ncbi.nlm.nih.gov/pubmed/26173755">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1958 href="http://dx.doi.org/10.1111/trf.13229">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d74286e1967 class=n-a></a>Eskazan AE: Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura. <i>Ann Hematol.</i> 2016; <b>95</b>(11): 1751–6. <a target=xrefwindow id=d74286e1975 href="http://www.ncbi.nlm.nih.gov/pubmed/27590601">PubMed Abstract </a> | <a target=xrefwindow id=d74286e1978 href="http://dx.doi.org/10.1007/s00277-016-2804-x">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726234012"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e1987 class=n-a></a>Patriquin CJ, Thomas MR, Dutt T, <i> et al.</i>: Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura. <i>Br J Haematol.</i> 2016; <b>173</b>(5): 779–85. <a target=xrefwindow id=d74286e1998 href="http://www.ncbi.nlm.nih.gov/pubmed/27009919">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2001 href="http://dx.doi.org/10.1111/bjh.13993">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726234012">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726135469"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e2014 class=n-a></a>Peyvandi F, Scully M, Kremer Hovinga JA, <i> et al.</i>: Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. <i>N Engl J Med.</i> 2016; <b>374</b>(6): 511–22. <a target=xrefwindow id=d74286e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/26863353">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2028 href="http://dx.doi.org/10.1056/NEJMoa1505533">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726135469">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727239145"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e2041 class=n-a></a>Page EE, Kremer Hovinga JA, Terrell DR, <i> et al.</i>: Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. <i>Blood.</i> 2016; <b>128</b>(17): 2175–8. <a target=xrefwindow id=d74286e2052 href="http://www.ncbi.nlm.nih.gov/pubmed/27625362">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2055 href="http://dx.doi.org/10.1182/blood-2016-06-724161">Publisher Full Text </a> | <a target=xrefwindow id=d74286e2059 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5084608">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727239145">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d74286e2072 class=n-a></a>Benhamou Y, Boelle PY, Baudin B, <i> et al.</i>: Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center. <i>J Thromb Haemost.</i> 2015; <b>13</b>(2): 293–302. <a target=xrefwindow id=d74286e2083 href="http://www.ncbi.nlm.nih.gov/pubmed/25403270">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2086 href="http://dx.doi.org/10.1111/jth.12790">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d74286e2096 class=n-a></a>Mariotte E, Azoulay E, Galicier L, <i> et al.</i>: Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. <i>Lancet Haematol.</i> 2016; <b>3</b>(5): e237–45. <a target=xrefwindow id=d74286e2107 href="http://www.ncbi.nlm.nih.gov/pubmed/27132698">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2110 href="http://dx.doi.org/10.1016/S2352-3026(16)30018-7">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727442587"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e2119 class=n-a></a>Falter T, Schmitt V, Herold S, <i> et al.</i>: Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura. <i>Transfusion.</i> 2017; <b>57</b>(5): 1152–62. <a target=xrefwindow id=d74286e2130 href="http://www.ncbi.nlm.nih.gov/pubmed/28337761">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2133 href="http://dx.doi.org/10.1111/trf.14060">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727442587">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d74286e2146 class=n-a></a>Han B, Page EE, Stewart LM, <i> et al.</i>: Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura. <i>Am J Hematol.</i> 2015; <b>90</b>(8): 709–14. <a target=xrefwindow id=d74286e2157 href="http://www.ncbi.nlm.nih.gov/pubmed/25975932">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2160 href="http://dx.doi.org/10.1002/ajh.24060">Publisher Full Text </a> | <a target=xrefwindow id=d74286e2164 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4509840">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d74286e2173 class=n-a></a>Jokiranta TS: HUS and atypical HUS. <i>Blood.</i> 2017; <b>129</b>(21): 2847–56. <a target=xrefwindow id=d74286e2181 href="http://www.ncbi.nlm.nih.gov/pubmed/28416508">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2184 href="http://dx.doi.org/10.1182/blood-2016-11-709865">Publisher Full Text </a> | <a target=xrefwindow id=d74286e2187 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5445567">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d74286e2196 class=n-a></a>Rodríguez de Córdoba S, Hidalgo MS, Pinto S, <i> et al.</i>: Genetics of atypical hemolytic uremic syndrome (aHUS). <i>Semin Thromb Hemost.</i> 2014; <b>40</b>(4): 422–30. <a target=xrefwindow id=d74286e2207 href="http://www.ncbi.nlm.nih.gov/pubmed/24799305">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2210 href="http://dx.doi.org/10.1055/s-0034-1375296">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725430703"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e2219 class=n-a></a>Gavriilaki E, Yuan X, Ye Z, <i> et al.</i>: Modified Ham test for atypical hemolytic uremic syndrome. <i>Blood.</i> 2015; <b>125</b>(23): 3637–46. <a target=xrefwindow id=d74286e2230 href="http://www.ncbi.nlm.nih.gov/pubmed/25862562">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2233 href="http://dx.doi.org/10.1182/blood-2015-02-629683">Publisher Full Text </a> | <a target=xrefwindow id=d74286e2237 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4784297">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725430703">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718017565"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d74286e2251 class=n-a></a>Legendre CM, Licht C, Muus P, <i> et al.</i>: Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. <i>N Engl J Med.</i> 2013; <b>368</b>(23): 2169–81. <a target=xrefwindow id=d74286e2262 href="http://www.ncbi.nlm.nih.gov/pubmed/23738544">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2265 href="http://dx.doi.org/10.1056/NEJMoa1208981">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718017565">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d74286e2278 class=n-a></a>Rodriguez E, Barrios C, Soler MJ: Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome? <i>Clin Kidney J.</i> 2017; <b>10</b>(3): 320–2. <a target=xrefwindow id=d74286e2286 href="http://www.ncbi.nlm.nih.gov/pubmed/28616209">PubMed Abstract </a> | <a target=xrefwindow id=d74286e2289 href="http://dx.doi.org/10.1093/ckj/sfx024">Publisher Full Text </a> | <a target=xrefwindow id=d74286e2292 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5466109">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 17 Jan 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-68.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-68.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Division of Hematology/Oncology, UT Southwestern Medical Center, Dallas, TX, USA<br/> <sup>2</sup> Division of Transfusion Medicine and Hemostasis, Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA<br/> <p> <div class=margin-bottom> Srikanth Nagalla <br/> <span>Roles: </span> Conceptualization, Resources, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Ravindra Sarode <br/> <span>Roles: </span> Conceptualization, Project Administration, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-68/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 17 Jan 2018, 7:68 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12309.1">https://doi.org/10.12688/f1000research.12309.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2018 Nagalla S and Sarode R. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13324 data-id=12309 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12309.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-68/v1/pdf?article_uuid=90dc86e1-fbac-47ca-802b-b29c0f9c828d" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12309.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Nagalla S and Sarode R. Recent advances in understanding and management of acquired thrombocytopenia [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):68 (<a href="https://doi.org/10.12688/f1000research.12309.1" target=_blank>https://doi.org/10.12688/f1000research.12309.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12309 id=mobile-track-article-signin-12309 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12309?target=/articles/7-68.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13324 /> <input name=articleId type=hidden value=12309 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>James B Bussel</strong>, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Medicine, New York Presbyterian Hospital, USA; Pediatric Hematology-Oncology, Weill Cornell Medical College, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Cindy E Neunert</strong>, Department of Pediatrics, Columbia University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 17 Jan 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-68.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-68.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=29586-29606></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=29585-29607></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-68/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>17 Jan 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>James B Bussel</strong>, Division of Pediatric Hematology/Oncology, Department of Pediatrics and Medicine, New York Presbyterian Hospital, USA; Pediatric Hematology-Oncology, Weill Cornell Medical College, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Cindy E Neunert</strong>, Department of Pediatrics, Columbia University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-68.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-68/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding and management...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-68/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-68/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-68/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Nagalla S and Sarode R');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-68/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-68",
            templates : {
                twitter : "Recent advances in understanding and management of acquired thrombocytopenia. Nagalla S and Sarode R, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-68/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding and management of acquired thrombocytopenia", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding and management of acquired thrombocytopenia", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12309/13324")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13324");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "29606": 0,
                           "29607": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "311e35a9-4b00-4ad6-9ebf-4a6dd4438d03";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-68.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-68.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-68.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-68.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-68.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>